Cell & gene therapy

Disease Area Cancer

Oncology Overhaul

| Neil Ward | 4 min read

What do advances in sequencing technology mean for research in cancer genomics?

Research Field Cell & gene therapy

Titan on the Horizon

| Angus Stewart | 6 min read

Can digital tools help cell and gene therapy evolve?

Research Field Cell & gene therapy

Welcome to the CRISPR Powerhouse

| Eric Rhodes | 4 min read

Why 2023 is the year that antibody manufacturers should embrace CRISPR gene editing.

Research Field Cell & gene therapy

Clearing Stress

| Michael R. Volkert | 5 min read

A gene therapy targeting a gene that regulates antioxidant action may effectively treat retinal degeneration

Research Field Cell & gene therapy

It’s a Drug’s Life

| Geoffrey Potjewyd | 5 min read

Many drugs are applied to the eye, yet we have little to no quantitative data on ocular drug metabolism – until now…

Research Field Cell & gene therapy

(Fibro)Blast-off!

| Hamid Khoja | 4 min read

In regenerative medicines and therapeutics, fibroblasts can offer significant advantages over stem cells, says Hamid Khoja

Disease Area Cell & gene therapy

The Genomic Revolution

| Stephanie Vine

Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views

Disease Area Cancer

Resolve Cancer

| Sponsored by 10x Genomics

Unravel the complexity of cancer biology and reveal insights to advance human health

Research Field Cancer

“Curing Cancer? That’s Cute”

| James Strachan

Cell and gene therapies are now considered mainstream therapeutic modalities – with revolutionary potential. But that hasn’t always been the case…

Research Field Pain & critical care

An Osteoarthritic Odyssey

Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register